Trends in otitis media-related health care use in the united states, 2001-2011

Tal Marom, Alai Tan, Gregg S. Wilkinson, Karen S. Pierson, Jean L. Freeman, Tasnee Chonmaitree

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Importance: Otitis media (OM) is a leading cause of pediatric health care visits and the most frequent reason children consume antibiotics or undergo surgery. During recent years, several Interventions: have been introduced aiming to decrease OM burden. Objective: To study the trend in OM-related health care use in the United States during the pneumococcal conjugate vaccine (PCV) era (2001-2011). Design, setting, and participants: An analysis of an insurance claims database of a large, nationwide managed health care plan was conducted. Enrolled children aged 6 years or younger with OM visits were identified. Main outcomes and measures: AnnualOMvisit rates, OM-related complications, and surgical Interventions: were analyzed. Results: Overall, 7.82 million unique children (5.51 million child-years) contributed 6.21 million primary OM visits; 52% were boys and 48% were younger than 2 years. There was a downward trend in OM visit rates from 2004 to 2011, with a significant drop that coincided with the advent of the 13-valent vaccine (PCV-13) in 2010. The observed OM visit rates in 2010 (1.00/child-year) and 2011 (0.81/child-year) were lower than the projected rates based on the 2005-2009 trend had there been no intervention (P < .001). Recurrent OM (≥3 OM visits within 6-month look-back) rates decreased at 0.003/child-year (95% CI, 0.002-0.004/child-year) in 2001-2009 and at 0.018/child-year (95% CI, 0.008-0.028/childyear) in 2010-2011. In the PCV-13 premarket years, there was a stable rate ratio (RR) between OM visit rates in children younger than 2 years and in those aged 2 to 6 years (RR, 1.38; 95% CI, 1.38-1.39); the RR decreased significantly (P < .001) during the transition year 2010 (RR 1.32; 95% CI, 1.31-1.33) and the postmarket year 2011 (RR 1.01; 95% CI, 1.00-1.02). Tympanic membrane perforation/otorrhea rates gradually increased (from 3721 per 100 000 OM child-years in 2001 to 4542 per 100 000 OM child-years in 2011; P < .001); the increase was significant only in the older children group. Mastoiditis rates substantially decreased (from 61 per 100 000 child-years in 2008 to 37 per 100 000 child-years in 2011; P < .001). Ventilating tube insertion rate decreased by 19% from 2010 to 2011 (P = .03). Conclusions and relevance: There was an overall downward trend in OM-related health care use from 2001 to 2011. The significant reduction in OM visit rates in 2010-2011 in children younger than 2 years coincided with the advent of PCV-13. Although tympanic membrane perforation/otorrhea rates steadily increased during that period, mastoiditis and ventilating tube insertion rates decreased in the last years of the study.

Original languageEnglish (US)
Pages (from-to)68-75
Number of pages8
JournalJAMA Pediatrics
Volume168
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Otitis Media
Delivery of Health Care
Conjugate Vaccines
Pneumococcal Vaccines
Mastoiditis
Tympanic Membrane Perforation
Insurance Claim Review
Managed Care Programs
Insurance

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Marom, T., Tan, A., Wilkinson, G. S., Pierson, K. S., Freeman, J. L., & Chonmaitree, T. (2014). Trends in otitis media-related health care use in the united states, 2001-2011. JAMA Pediatrics, 168(1), 68-75. https://doi.org/10.1001/jamapediatrics.2013.3924

Trends in otitis media-related health care use in the united states, 2001-2011. / Marom, Tal; Tan, Alai; Wilkinson, Gregg S.; Pierson, Karen S.; Freeman, Jean L.; Chonmaitree, Tasnee.

In: JAMA Pediatrics, Vol. 168, No. 1, 01.2014, p. 68-75.

Research output: Contribution to journalArticle

Marom, T, Tan, A, Wilkinson, GS, Pierson, KS, Freeman, JL & Chonmaitree, T 2014, 'Trends in otitis media-related health care use in the united states, 2001-2011', JAMA Pediatrics, vol. 168, no. 1, pp. 68-75. https://doi.org/10.1001/jamapediatrics.2013.3924
Marom T, Tan A, Wilkinson GS, Pierson KS, Freeman JL, Chonmaitree T. Trends in otitis media-related health care use in the united states, 2001-2011. JAMA Pediatrics. 2014 Jan;168(1):68-75. https://doi.org/10.1001/jamapediatrics.2013.3924
Marom, Tal ; Tan, Alai ; Wilkinson, Gregg S. ; Pierson, Karen S. ; Freeman, Jean L. ; Chonmaitree, Tasnee. / Trends in otitis media-related health care use in the united states, 2001-2011. In: JAMA Pediatrics. 2014 ; Vol. 168, No. 1. pp. 68-75.
@article{035cac9b900c4d73ab7166c6302eb203,
title = "Trends in otitis media-related health care use in the united states, 2001-2011",
abstract = "Importance: Otitis media (OM) is a leading cause of pediatric health care visits and the most frequent reason children consume antibiotics or undergo surgery. During recent years, several Interventions: have been introduced aiming to decrease OM burden. Objective: To study the trend in OM-related health care use in the United States during the pneumococcal conjugate vaccine (PCV) era (2001-2011). Design, setting, and participants: An analysis of an insurance claims database of a large, nationwide managed health care plan was conducted. Enrolled children aged 6 years or younger with OM visits were identified. Main outcomes and measures: AnnualOMvisit rates, OM-related complications, and surgical Interventions: were analyzed. Results: Overall, 7.82 million unique children (5.51 million child-years) contributed 6.21 million primary OM visits; 52{\%} were boys and 48{\%} were younger than 2 years. There was a downward trend in OM visit rates from 2004 to 2011, with a significant drop that coincided with the advent of the 13-valent vaccine (PCV-13) in 2010. The observed OM visit rates in 2010 (1.00/child-year) and 2011 (0.81/child-year) were lower than the projected rates based on the 2005-2009 trend had there been no intervention (P < .001). Recurrent OM (≥3 OM visits within 6-month look-back) rates decreased at 0.003/child-year (95{\%} CI, 0.002-0.004/child-year) in 2001-2009 and at 0.018/child-year (95{\%} CI, 0.008-0.028/childyear) in 2010-2011. In the PCV-13 premarket years, there was a stable rate ratio (RR) between OM visit rates in children younger than 2 years and in those aged 2 to 6 years (RR, 1.38; 95{\%} CI, 1.38-1.39); the RR decreased significantly (P < .001) during the transition year 2010 (RR 1.32; 95{\%} CI, 1.31-1.33) and the postmarket year 2011 (RR 1.01; 95{\%} CI, 1.00-1.02). Tympanic membrane perforation/otorrhea rates gradually increased (from 3721 per 100 000 OM child-years in 2001 to 4542 per 100 000 OM child-years in 2011; P < .001); the increase was significant only in the older children group. Mastoiditis rates substantially decreased (from 61 per 100 000 child-years in 2008 to 37 per 100 000 child-years in 2011; P < .001). Ventilating tube insertion rate decreased by 19{\%} from 2010 to 2011 (P = .03). Conclusions and relevance: There was an overall downward trend in OM-related health care use from 2001 to 2011. The significant reduction in OM visit rates in 2010-2011 in children younger than 2 years coincided with the advent of PCV-13. Although tympanic membrane perforation/otorrhea rates steadily increased during that period, mastoiditis and ventilating tube insertion rates decreased in the last years of the study.",
author = "Tal Marom and Alai Tan and Wilkinson, {Gregg S.} and Pierson, {Karen S.} and Freeman, {Jean L.} and Tasnee Chonmaitree",
year = "2014",
month = "1",
doi = "10.1001/jamapediatrics.2013.3924",
language = "English (US)",
volume = "168",
pages = "68--75",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "1",

}

TY - JOUR

T1 - Trends in otitis media-related health care use in the united states, 2001-2011

AU - Marom, Tal

AU - Tan, Alai

AU - Wilkinson, Gregg S.

AU - Pierson, Karen S.

AU - Freeman, Jean L.

AU - Chonmaitree, Tasnee

PY - 2014/1

Y1 - 2014/1

N2 - Importance: Otitis media (OM) is a leading cause of pediatric health care visits and the most frequent reason children consume antibiotics or undergo surgery. During recent years, several Interventions: have been introduced aiming to decrease OM burden. Objective: To study the trend in OM-related health care use in the United States during the pneumococcal conjugate vaccine (PCV) era (2001-2011). Design, setting, and participants: An analysis of an insurance claims database of a large, nationwide managed health care plan was conducted. Enrolled children aged 6 years or younger with OM visits were identified. Main outcomes and measures: AnnualOMvisit rates, OM-related complications, and surgical Interventions: were analyzed. Results: Overall, 7.82 million unique children (5.51 million child-years) contributed 6.21 million primary OM visits; 52% were boys and 48% were younger than 2 years. There was a downward trend in OM visit rates from 2004 to 2011, with a significant drop that coincided with the advent of the 13-valent vaccine (PCV-13) in 2010. The observed OM visit rates in 2010 (1.00/child-year) and 2011 (0.81/child-year) were lower than the projected rates based on the 2005-2009 trend had there been no intervention (P < .001). Recurrent OM (≥3 OM visits within 6-month look-back) rates decreased at 0.003/child-year (95% CI, 0.002-0.004/child-year) in 2001-2009 and at 0.018/child-year (95% CI, 0.008-0.028/childyear) in 2010-2011. In the PCV-13 premarket years, there was a stable rate ratio (RR) between OM visit rates in children younger than 2 years and in those aged 2 to 6 years (RR, 1.38; 95% CI, 1.38-1.39); the RR decreased significantly (P < .001) during the transition year 2010 (RR 1.32; 95% CI, 1.31-1.33) and the postmarket year 2011 (RR 1.01; 95% CI, 1.00-1.02). Tympanic membrane perforation/otorrhea rates gradually increased (from 3721 per 100 000 OM child-years in 2001 to 4542 per 100 000 OM child-years in 2011; P < .001); the increase was significant only in the older children group. Mastoiditis rates substantially decreased (from 61 per 100 000 child-years in 2008 to 37 per 100 000 child-years in 2011; P < .001). Ventilating tube insertion rate decreased by 19% from 2010 to 2011 (P = .03). Conclusions and relevance: There was an overall downward trend in OM-related health care use from 2001 to 2011. The significant reduction in OM visit rates in 2010-2011 in children younger than 2 years coincided with the advent of PCV-13. Although tympanic membrane perforation/otorrhea rates steadily increased during that period, mastoiditis and ventilating tube insertion rates decreased in the last years of the study.

AB - Importance: Otitis media (OM) is a leading cause of pediatric health care visits and the most frequent reason children consume antibiotics or undergo surgery. During recent years, several Interventions: have been introduced aiming to decrease OM burden. Objective: To study the trend in OM-related health care use in the United States during the pneumococcal conjugate vaccine (PCV) era (2001-2011). Design, setting, and participants: An analysis of an insurance claims database of a large, nationwide managed health care plan was conducted. Enrolled children aged 6 years or younger with OM visits were identified. Main outcomes and measures: AnnualOMvisit rates, OM-related complications, and surgical Interventions: were analyzed. Results: Overall, 7.82 million unique children (5.51 million child-years) contributed 6.21 million primary OM visits; 52% were boys and 48% were younger than 2 years. There was a downward trend in OM visit rates from 2004 to 2011, with a significant drop that coincided with the advent of the 13-valent vaccine (PCV-13) in 2010. The observed OM visit rates in 2010 (1.00/child-year) and 2011 (0.81/child-year) were lower than the projected rates based on the 2005-2009 trend had there been no intervention (P < .001). Recurrent OM (≥3 OM visits within 6-month look-back) rates decreased at 0.003/child-year (95% CI, 0.002-0.004/child-year) in 2001-2009 and at 0.018/child-year (95% CI, 0.008-0.028/childyear) in 2010-2011. In the PCV-13 premarket years, there was a stable rate ratio (RR) between OM visit rates in children younger than 2 years and in those aged 2 to 6 years (RR, 1.38; 95% CI, 1.38-1.39); the RR decreased significantly (P < .001) during the transition year 2010 (RR 1.32; 95% CI, 1.31-1.33) and the postmarket year 2011 (RR 1.01; 95% CI, 1.00-1.02). Tympanic membrane perforation/otorrhea rates gradually increased (from 3721 per 100 000 OM child-years in 2001 to 4542 per 100 000 OM child-years in 2011; P < .001); the increase was significant only in the older children group. Mastoiditis rates substantially decreased (from 61 per 100 000 child-years in 2008 to 37 per 100 000 child-years in 2011; P < .001). Ventilating tube insertion rate decreased by 19% from 2010 to 2011 (P = .03). Conclusions and relevance: There was an overall downward trend in OM-related health care use from 2001 to 2011. The significant reduction in OM visit rates in 2010-2011 in children younger than 2 years coincided with the advent of PCV-13. Although tympanic membrane perforation/otorrhea rates steadily increased during that period, mastoiditis and ventilating tube insertion rates decreased in the last years of the study.

UR - http://www.scopus.com/inward/record.url?scp=84892695693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892695693&partnerID=8YFLogxK

U2 - 10.1001/jamapediatrics.2013.3924

DO - 10.1001/jamapediatrics.2013.3924

M3 - Article

VL - 168

SP - 68

EP - 75

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 1

ER -